Brilliant Blue G Ophthalmic Solution: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

13 April 2025

  • curprev 13:0213:02, 13 April 2025 Omid Afkhami-Ardakani talk contribs 4,137 bytes +4,137 Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami-Ardakani |genericName=Brilliant Blue G |aOrAn=a |drugClass=Disclosing Agent​ |indicationType=procedure |indication=staining the internal limiting membrane (ILM) during ophthalmic surgery. |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |fdaLIADAdult=Inject TissueBlue 0.025% directly into a Balanced Salt Solutio..."
Retrieved from "https://www.wikidoc.org/index.php/Brilliant_Blue_G_Ophthalmic_Solution"